Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party: Correspondence

British Journal of Haematology

Volumn 150, Issue 3, 2010, Pages 377-379

  Marsh, Judith ^a   Socie, Gerard ^b   Tichelli, Andre ^c   Schrezenmeier, Hubert ^d   Hochsmann, Britta ^d   Risitano, Antonio M ^e   Fuehrer, Monika ^f   Bekassy, Albert N ^g   Korthof, Elizabeth T ^h   Locasciulli, Anna ⁱ   Ljungman, Per ^j   Bacigalupo, Andrea ^k   Camitta, Bruce ^l   Young, Neal S ^m   Passweg, Jakob ⁿ  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b SAINT LOUIS HOSPITAL   (France)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF ULM   (Germany)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^j KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^k UNIVERSITY OF GENOA   (Italy)

^l MEDICAL COLLEGE OF WISCONSIN   (United States)

^m NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

ⁿ GENEVA UNIVERSITY HOSPITALS   (Switzerland)

more..

Author keywords

antithymocyte globulin; aplastic anaemia; irradiated blood products; transfusion associated graft versus host disease

Indexed keywords

THYMOCYTE ANTIBODY;

APLASTIC ANEMIA; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; LETTER; LYMPHOCYTOPENIA; PRIORITY JOURNAL; RISK REDUCTION; THROMBOCYTE TRANSFUSION;

ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; BLOOD; BLOOD COMPONENT TRANSFUSION; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; HEALTH CARE SURVEYS; HUMANS; IMMUNOSUPPRESSIVE AGENTS;

EID: 77954592717     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08200.x     Document Type: Letter

References (10)

1. Agbaht, K., Altintas, N.D., Topeli, A., Gokoz, O. Ozcebe, O. (2007) Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature. Transfusion, 47, 1405 1411.
2. Bean, M.A., Graham, T., Appelbaum, F.R., Deeg, H.J., Scheuning, F., Sale, G.E. Storb, R. (1994) Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitisation to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts. Transplantation, 57, 423 426.
3. British Committee for Standards in Haematology Blood Transfusion Task Force. (1996) Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft versus host disease. Transfusion Medicine, 6, 261 267.
4. Killick, S.B., Win, N., Marsh, J.C.W., Kaye, T., Yandle, A., Humphries, C. Knowles, S.M. (1997) Pilot study of HLA alloimmunization after transfusion with pre-storage leucodepleted blood products in aplastic anaemia. British Journal of Haematology, 97, 677 684.
5. Laundy, G., Bradley, B., Rees, B., Younie, M. Hows, J. (2004) Incidence and specificity of HLA antibodies in multi-transfused patients with acquired aplastic anaemia. Transfusion, 44, 814 825.
6. Marsh, J.C.W., Ball, S.E., Cavenagh, J., Darbyshire, P., Dokal, I., Gordon- Smith, E.C., Keidan, J., Laurie, A., Martin, A., Mercieca, J., Killick, S.B., Stewart, R. Yin, J.A.L. (2009) Guidelines for the diagnosis and management of aplastic anaemia. British Journal of Haematology, 147, 43 70.
7. Scheinberg, P., Fischer, S., Nunez, L., Wu, C.E., Cohen, J., Young, N. Barrett, A. (2007) Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood, 109, 3219 3224.
8. The Board of the German Medical Association on the recommendation of the Scientific Advisory Board. (2009) Cross-sectional guidelines for therapy in blood components and plasma derivatives, 11. Adverse reactions. Transfusion Medicine and Hemotherapy, 36, 465 478.
9. The Trial to reduce Alloimmunisation to Platelets study group. (1997) Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunisation and refractoriness to platelet transfusions. New England Journal of Medicine, 337, 1861 1869.
10. Williamson, L.M., Stainsby, D., Jones, H., Love, E., Chapman, C.E., Navarrete, C., Lucas, G., Beatty, C., Casbard, A. Cohen, H. (2007) The impact of universal leukodepletion of the blood supply on hemovigilance reports of post transfusion purpura and transfusion-associated graft-versus-host disease. Transfusion, 47, 1455 1467.